Plain-English translation of NCT04878094 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing the PINPOINT imaging system, a special camera that uses a glowing dye to show blood flow in the bowel during ovarian cancer surgery. The study wants to know if using this real-time imaging during the operation can help surgeons catch and fix potential problems before they happen, reducing the risk of serious complications after surgery. Half of the participants will receive standard surgery, and half will have surgery with this additional imaging technology.
After bowel surgery, sometimes complications like leaks can develop at the connection point where the bowel is sewn back together. This trial exists to see if the new imaging technology can help surgeons identify areas of poor blood flow during surgery and fix them right away, which could prevent these dangerous complications from happening.
If you qualify and choose to participate, you will be randomly assigned to either standard surgery or surgery with the special imaging system. Your surgery will proceed as planned for your ovarian cancer treatment. If you are in the imaging group, the surgeon will use the PINPOINT camera during your operation to check the blood flow in your bowel and the connections made during surgery. The trial participation essentially happens during your operation — there are no extra visits or long-term commitments beyond your normal post-surgery follow-up care.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States